23
KIT
YpsoMed
The company's Mylife Loop to
integrate Abbott's future dual
glucose-ketone sensor (currently
under development) into its system,
combining Mylife YpsoPump and
the CamAPS FX app. "By integrating
Abbott's future dual glucose-ketone
sensor into mylife Loop, we aim to
offer people with diabetes greater
safety and confidence in their daily
therapy," said Sébastien Delarive,
Chief Business Officer Diabetes Care
at Ypsomed.
"We are excited to collaborate
with Abbott on this important
innovation," said Prof. Roman
Hovorka, Director of CamDiab Ltd.
"By incorporating future ketone
monitoring alongside glucose data
with the Mylife CamAPS FX app, we
are taking a major step forward in
delivering a closed-loop solution
that is designed to enhance safety
and reduces burden for people - and
their loved ones living with Type 1
diabetes."
Subject to regulatory approval,
the integrated solution is expected to
become available in selected markets
following the commercial release of
Abbott's dual glucose-ketone sensor.
www.ypsomed.com
The components of YpsoMed's Mylife Loop.
By incorporating
future ketone
monitoring
alongside glucose
data with the
Mylife CamAPS
FX app, we are
taking a major
step forward
in delivering
a closed-loop
solution that
is designed to
enhance safety
and reduces
burden for people
- and their loved
ones living with
Type 1 diabetes.
- Prof Roman
Hovorka